Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

CompletedOBSERVATIONAL
Enrollment

317

Participants

Timeline

Start Date

May 17, 2020

Primary Completion Date

July 23, 2021

Study Completion Date

August 30, 2021

Conditions
Community Acquired PneumoniaComplicated Skin and Soft Tissue Infection
Interventions
DRUG

Zinforo (ceftaroline fosamil)

IV Solution

Trial Locations (26)

8035

Hospital Universitario Valle de Hebrón, Barcelona

10141

Aou Citta Della Salute E Della Scienza Scdu Malattie Infettive 2, Turin

12462

Attikon University General Hospital, Athens

21000

CHU Francois Mitterrand, Dijon

25123

Asst Spedali Civili Brescia and Universita Degli Studi di Brescia, Brescia

26504

Patras University Medical School, Pátrai

28034

Hospital Ramon y Cajal, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

33100

Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Presidio Ospedaliero Universitario Santa, Udine

38700

CHU de Grenoble Alpes, Grenoble

41110

General University Hospital of Larissa, Larissa

44093

CHU Nantes, Nantes

50025

Clínica Las Américas, Medellín

54621

AHEPA General University Hospital of Thessaloniki, Thessaloniki

69004

Croix-Rousse hospital, Hospices Civils de Lyon, Lyon

71110

University Hospital of Heraklion, Heraklion

80131

AORN Ospedali dei Colli - Ospedale Monaldi, Napoli

Azienda Ospedaliera Dei Colli, Napoli

426039

BUZ UR First Republican Clinical Hospital under the Ministry of Healthcare of Udmurt Republic UR, Izhevsk

450005

Republican Clinical Hospital named after G.G. Kuvatova, Ufa

660002

E.S.E. Hospital Universitario San Jorge de Pereira, Pereira

760032

Fundación Valle del Lili, Santiago de Cali

52010-075

Real Hospital Português de Beneficência, Recife

50070-480

Hospital Esperança, Recife

Unknown

Centro médico Imbanaco, Santiago de Cali

08036

Hospital Clínic, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY